nodes	percent_of_prediction	percent_of_DWPC	metapath
Disopyramide—SCN5A—dilated cardiomyopathy	0.754	1	CbGaD
Disopyramide—SCN5A—purkinje fiber—dilated cardiomyopathy	0.035	0.295	CbGeAlD
Disopyramide—KCND3—endocardium—dilated cardiomyopathy	0.0301	0.253	CbGeAlD
Disopyramide—SCN5A—endocardium—dilated cardiomyopathy	0.018	0.152	CbGeAlD
Disopyramide—SCN5A—sinoatrial node—dilated cardiomyopathy	0.0171	0.144	CbGeAlD
Disopyramide—Acute retention of urine—Furosemide—dilated cardiomyopathy	0.0119	0.147	CcSEcCtD
Disopyramide—Cardiac fibrillation—Lisinopril—dilated cardiomyopathy	0.0036	0.0443	CcSEcCtD
Disopyramide—KCND2—cardiac ventricle—dilated cardiomyopathy	0.0029	0.0244	CbGeAlD
Disopyramide—Abdominal bloating—Furosemide—dilated cardiomyopathy	0.00263	0.0323	CcSEcCtD
Disopyramide—KCND3—cardiac ventricle—dilated cardiomyopathy	0.00253	0.0213	CbGeAlD
Disopyramide—KCND3—myocardium—dilated cardiomyopathy	0.00238	0.02	CbGeAlD
Disopyramide—Gynaecomastia—Spironolactone—dilated cardiomyopathy	0.00206	0.0253	CcSEcCtD
Disopyramide—KCND2—heart—dilated cardiomyopathy	0.00191	0.016	CbGeAlD
Disopyramide—KCND3—heart—dilated cardiomyopathy	0.00166	0.014	CbGeAlD
Disopyramide—SCN5A—cardiac ventricle—dilated cardiomyopathy	0.00152	0.0128	CbGeAlD
Disopyramide—SCN5A—myocardium—dilated cardiomyopathy	0.00143	0.012	CbGeAlD
Disopyramide—Jaundice cholestatic—Furosemide—dilated cardiomyopathy	0.00142	0.0175	CcSEcCtD
Disopyramide—KCND3—cardiac atrium—dilated cardiomyopathy	0.00142	0.012	CbGeAlD
Disopyramide—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00133	0.0163	CcSEcCtD
Disopyramide—Drowsiness—Spironolactone—dilated cardiomyopathy	0.00129	0.0158	CcSEcCtD
Disopyramide—Ventricular fibrillation—Lisinopril—dilated cardiomyopathy	0.00123	0.0151	CcSEcCtD
Disopyramide—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.0012	0.0148	CcSEcCtD
Disopyramide—Jaundice cholestatic—Lisinopril—dilated cardiomyopathy	0.00107	0.0131	CcSEcCtD
Disopyramide—SCN5A—heart—dilated cardiomyopathy	0.000997	0.0084	CbGeAlD
Disopyramide—Creatinine increased—Lisinopril—dilated cardiomyopathy	0.000986	0.0121	CcSEcCtD
Disopyramide—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.000939	0.0116	CcSEcCtD
Disopyramide—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.000933	0.0115	CcSEcCtD
Disopyramide—Malaise—Spironolactone—dilated cardiomyopathy	0.000906	0.0112	CcSEcCtD
Disopyramide—Blood urea increased—Lisinopril—dilated cardiomyopathy	0.000886	0.0109	CcSEcCtD
Disopyramide—Urinary retention—Furosemide—dilated cardiomyopathy	0.000863	0.0106	CcSEcCtD
Disopyramide—SCN5A—cardiac atrium—dilated cardiomyopathy	0.000853	0.00718	CbGeAlD
Disopyramide—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.000851	0.0105	CcSEcCtD
Disopyramide—CHRM2—heart—dilated cardiomyopathy	0.000849	0.00715	CbGeAlD
Disopyramide—Discomfort—Spironolactone—dilated cardiomyopathy	0.000845	0.0104	CcSEcCtD
Disopyramide—Confusional state—Spironolactone—dilated cardiomyopathy	0.000827	0.0102	CcSEcCtD
Disopyramide—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.000826	0.0102	CcSEcCtD
Disopyramide—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.000803	0.00988	CcSEcCtD
Disopyramide—Muscular weakness—Furosemide—dilated cardiomyopathy	0.000801	0.00986	CcSEcCtD
Disopyramide—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00079	0.00972	CcSEcCtD
Disopyramide—Somnolence—Spironolactone—dilated cardiomyopathy	0.000729	0.00897	CcSEcCtD
Disopyramide—Pollakiuria—Furosemide—dilated cardiomyopathy	0.000725	0.00892	CcSEcCtD
Disopyramide—Drowsiness—Furosemide—dilated cardiomyopathy	0.0007	0.00861	CcSEcCtD
Disopyramide—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.000698	0.00859	CcSEcCtD
Disopyramide—Diplopia—Lisinopril—dilated cardiomyopathy	0.000681	0.00838	CcSEcCtD
Disopyramide—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000676	0.00832	CcSEcCtD
Disopyramide—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.000653	0.00804	CcSEcCtD
Disopyramide—Urticaria—Spironolactone—dilated cardiomyopathy	0.000652	0.00802	CcSEcCtD
Disopyramide—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000648	0.00798	CcSEcCtD
Disopyramide—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.000648	0.00797	CcSEcCtD
Disopyramide—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.000638	0.00785	CcSEcCtD
Disopyramide—Pruritus—Spironolactone—dilated cardiomyopathy	0.00058	0.00714	CcSEcCtD
Disopyramide—Sweating increased—Lisinopril—dilated cardiomyopathy	0.000574	0.00706	CcSEcCtD
Disopyramide—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000561	0.00691	CcSEcCtD
Disopyramide—Arrhythmia—Furosemide—dilated cardiomyopathy	0.000561	0.00691	CcSEcCtD
Disopyramide—Dysuria—Lisinopril—dilated cardiomyopathy	0.000551	0.00678	CcSEcCtD
Disopyramide—Neutropenia—Lisinopril—dilated cardiomyopathy	0.000551	0.00678	CcSEcCtD
Disopyramide—Dizziness—Spironolactone—dilated cardiomyopathy	0.000542	0.00668	CcSEcCtD
Disopyramide—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.000542	0.00667	CcSEcCtD
Disopyramide—Flatulence—Furosemide—dilated cardiomyopathy	0.000539	0.00663	CcSEcCtD
Disopyramide—Weight increased—Lisinopril—dilated cardiomyopathy	0.000536	0.00659	CcSEcCtD
Disopyramide—Dysgeusia—Furosemide—dilated cardiomyopathy	0.000535	0.00659	CcSEcCtD
Disopyramide—Depression—Lisinopril—dilated cardiomyopathy	0.000524	0.00644	CcSEcCtD
Disopyramide—Vomiting—Spironolactone—dilated cardiomyopathy	0.000522	0.00642	CcSEcCtD
Disopyramide—Rash—Spironolactone—dilated cardiomyopathy	0.000517	0.00636	CcSEcCtD
Disopyramide—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000517	0.00636	CcSEcCtD
Disopyramide—Vision blurred—Furosemide—dilated cardiomyopathy	0.000515	0.00634	CcSEcCtD
Disopyramide—Headache—Spironolactone—dilated cardiomyopathy	0.000514	0.00632	CcSEcCtD
Disopyramide—Vertigo—Furosemide—dilated cardiomyopathy	0.000491	0.00605	CcSEcCtD
Disopyramide—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00049	0.00603	CcSEcCtD
Disopyramide—Nausea—Spironolactone—dilated cardiomyopathy	0.000487	0.006	CcSEcCtD
Disopyramide—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00048	0.0059	CcSEcCtD
Disopyramide—Hepatitis—Lisinopril—dilated cardiomyopathy	0.000471	0.0058	CcSEcCtD
Disopyramide—Dry mouth—Furosemide—dilated cardiomyopathy	0.000455	0.0056	CcSEcCtD
Disopyramide—Confusional state—Furosemide—dilated cardiomyopathy	0.00045	0.00554	CcSEcCtD
Disopyramide—Shock—Furosemide—dilated cardiomyopathy	0.000439	0.0054	CcSEcCtD
Disopyramide—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000437	0.00538	CcSEcCtD
Disopyramide—Skin disorder—Furosemide—dilated cardiomyopathy	0.000433	0.00533	CcSEcCtD
Disopyramide—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000431	0.00531	CcSEcCtD
Disopyramide—Anorexia—Furosemide—dilated cardiomyopathy	0.000425	0.00523	CcSEcCtD
Disopyramide—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000421	0.00518	CcSEcCtD
Disopyramide—Hypotension—Furosemide—dilated cardiomyopathy	0.000417	0.00513	CcSEcCtD
Disopyramide—Flatulence—Lisinopril—dilated cardiomyopathy	0.000404	0.00498	CcSEcCtD
Disopyramide—Tension—Lisinopril—dilated cardiomyopathy	0.000403	0.00495	CcSEcCtD
Disopyramide—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000402	0.00494	CcSEcCtD
Disopyramide—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000401	0.00493	CcSEcCtD
Disopyramide—Nervousness—Lisinopril—dilated cardiomyopathy	0.000398	0.0049	CcSEcCtD
Disopyramide—Somnolence—Furosemide—dilated cardiomyopathy	0.000397	0.00488	CcSEcCtD
Disopyramide—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000388	0.00477	CcSEcCtD
Disopyramide—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000387	0.00476	CcSEcCtD
Disopyramide—Fatigue—Furosemide—dilated cardiomyopathy	0.000385	0.00473	CcSEcCtD
Disopyramide—Pain—Furosemide—dilated cardiomyopathy	0.000382	0.0047	CcSEcCtD
Disopyramide—Constipation—Furosemide—dilated cardiomyopathy	0.000382	0.0047	CcSEcCtD
Disopyramide—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000381	0.00468	CcSEcCtD
Disopyramide—Angioedema—Lisinopril—dilated cardiomyopathy	0.000375	0.00461	CcSEcCtD
Disopyramide—Malaise—Lisinopril—dilated cardiomyopathy	0.00037	0.00455	CcSEcCtD
Disopyramide—Vertigo—Lisinopril—dilated cardiomyopathy	0.000369	0.00454	CcSEcCtD
Disopyramide—Syncope—Lisinopril—dilated cardiomyopathy	0.000368	0.00453	CcSEcCtD
Disopyramide—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000368	0.00453	CcSEcCtD
Disopyramide—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000361	0.00444	CcSEcCtD
Disopyramide—Urticaria—Furosemide—dilated cardiomyopathy	0.000355	0.00436	CcSEcCtD
Disopyramide—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000353	0.00434	CcSEcCtD
Disopyramide—Chest pain—Lisinopril—dilated cardiomyopathy	0.000349	0.0043	CcSEcCtD
Disopyramide—Discomfort—Lisinopril—dilated cardiomyopathy	0.000345	0.00425	CcSEcCtD
Disopyramide—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000342	0.0042	CcSEcCtD
Disopyramide—Confusional state—Lisinopril—dilated cardiomyopathy	0.000338	0.00415	CcSEcCtD
Disopyramide—Oedema—Lisinopril—dilated cardiomyopathy	0.000335	0.00412	CcSEcCtD
Disopyramide—Shock—Lisinopril—dilated cardiomyopathy	0.000329	0.00405	CcSEcCtD
Disopyramide—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000328	0.00403	CcSEcCtD
Disopyramide—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000325	0.004	CcSEcCtD
Disopyramide—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000324	0.00398	CcSEcCtD
Disopyramide—Asthenia—Furosemide—dilated cardiomyopathy	0.00032	0.00394	CcSEcCtD
Disopyramide—Anorexia—Lisinopril—dilated cardiomyopathy	0.000319	0.00393	CcSEcCtD
Disopyramide—Pruritus—Furosemide—dilated cardiomyopathy	0.000316	0.00389	CcSEcCtD
Disopyramide—Hypotension—Lisinopril—dilated cardiomyopathy	0.000313	0.00385	CcSEcCtD
Disopyramide—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000305	0.00376	CcSEcCtD
Disopyramide—Insomnia—Lisinopril—dilated cardiomyopathy	0.000303	0.00373	CcSEcCtD
Disopyramide—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000301	0.0037	CcSEcCtD
Disopyramide—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000299	0.00367	CcSEcCtD
Disopyramide—Somnolence—Lisinopril—dilated cardiomyopathy	0.000298	0.00366	CcSEcCtD
Disopyramide—Dizziness—Furosemide—dilated cardiomyopathy	0.000295	0.00363	CcSEcCtD
Disopyramide—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000295	0.00363	CcSEcCtD
Disopyramide—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000291	0.00358	CcSEcCtD
Disopyramide—Fatigue—Lisinopril—dilated cardiomyopathy	0.000289	0.00355	CcSEcCtD
Disopyramide—Pain—Lisinopril—dilated cardiomyopathy	0.000286	0.00352	CcSEcCtD
Disopyramide—Constipation—Lisinopril—dilated cardiomyopathy	0.000286	0.00352	CcSEcCtD
Disopyramide—Vomiting—Furosemide—dilated cardiomyopathy	0.000284	0.00349	CcSEcCtD
Disopyramide—Rash—Furosemide—dilated cardiomyopathy	0.000281	0.00346	CcSEcCtD
Disopyramide—Dermatitis—Furosemide—dilated cardiomyopathy	0.000281	0.00346	CcSEcCtD
Disopyramide—Headache—Furosemide—dilated cardiomyopathy	0.00028	0.00344	CcSEcCtD
Disopyramide—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000276	0.0034	CcSEcCtD
Disopyramide—Urticaria—Lisinopril—dilated cardiomyopathy	0.000266	0.00327	CcSEcCtD
Disopyramide—Nausea—Furosemide—dilated cardiomyopathy	0.000265	0.00326	CcSEcCtD
Disopyramide—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000265	0.00326	CcSEcCtD
Disopyramide—Asthenia—Lisinopril—dilated cardiomyopathy	0.00024	0.00296	CcSEcCtD
Disopyramide—Pruritus—Lisinopril—dilated cardiomyopathy	0.000237	0.00292	CcSEcCtD
Disopyramide—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000229	0.00282	CcSEcCtD
Disopyramide—Dizziness—Lisinopril—dilated cardiomyopathy	0.000221	0.00272	CcSEcCtD
Disopyramide—Vomiting—Lisinopril—dilated cardiomyopathy	0.000213	0.00262	CcSEcCtD
Disopyramide—Rash—Lisinopril—dilated cardiomyopathy	0.000211	0.0026	CcSEcCtD
Disopyramide—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000211	0.0026	CcSEcCtD
Disopyramide—Headache—Lisinopril—dilated cardiomyopathy	0.00021	0.00258	CcSEcCtD
Disopyramide—Nausea—Lisinopril—dilated cardiomyopathy	0.000199	0.00245	CcSEcCtD
Disopyramide—SLC22A2—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000182	0.00399	CbGpPWpGaD
Disopyramide—SCN5A—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000182	0.00398	CbGpPWpGaD
Disopyramide—CHRM2—GPCRs, Other—CXCR3—dilated cardiomyopathy	0.000181	0.00395	CbGpPWpGaD
Disopyramide—SLC22A1—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.00017	0.00371	CbGpPWpGaD
Disopyramide—KCND3—Neuronal System—RAF1—dilated cardiomyopathy	0.00017	0.00371	CbGpPWpGaD
Disopyramide—SLC22A2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00016	0.0035	CbGpPWpGaD
Disopyramide—SCN5A—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000158	0.00345	CbGpPWpGaD
Disopyramide—SCN5A—Axon guidance—PSEN2—dilated cardiomyopathy	0.000154	0.00336	CbGpPWpGaD
Disopyramide—SLC22A2—Neuronal System—ACTN2—dilated cardiomyopathy	0.000154	0.00336	CbGpPWpGaD
Disopyramide—KCND2—Neuronal System—RAF1—dilated cardiomyopathy	0.000151	0.00331	CbGpPWpGaD
Disopyramide—SLC22A1—Neuronal System—ABCC9—dilated cardiomyopathy	0.000149	0.00326	CbGpPWpGaD
Disopyramide—CHRM3—GPCRs, Other—ADRB2—dilated cardiomyopathy	0.000143	0.00313	CbGpPWpGaD
Disopyramide—SLC22A1—Neuronal System—ACTN2—dilated cardiomyopathy	0.000143	0.00313	CbGpPWpGaD
Disopyramide—CHRM2—GPCRs, Other—ADRB2—dilated cardiomyopathy	0.000142	0.0031	CbGpPWpGaD
Disopyramide—CHRM1—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.00012	0.00261	CbGpPWpGaD
Disopyramide—CHRM3—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.000119	0.0026	CbGpPWpGaD
Disopyramide—CHRM2—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.000118	0.00258	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—PSEN2—dilated cardiomyopathy	0.00011	0.0024	CbGpPWpGaD
Disopyramide—CHRM1—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	9.87e-05	0.00216	CbGpPWpGaD
Disopyramide—CHRM3—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	9.84e-05	0.00215	CbGpPWpGaD
Disopyramide—CHRM2—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	9.75e-05	0.00213	CbGpPWpGaD
Disopyramide—CHRM1—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	9.69e-05	0.00212	CbGpPWpGaD
Disopyramide—CHRM3—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	9.66e-05	0.00211	CbGpPWpGaD
Disopyramide—SCN5A—Axon guidance—ITGB1—dilated cardiomyopathy	9.62e-05	0.0021	CbGpPWpGaD
Disopyramide—CHRM2—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	9.57e-05	0.00209	CbGpPWpGaD
Disopyramide—SLC22A2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	9.53e-05	0.00208	CbGpPWpGaD
Disopyramide—CHRM2—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	9.4e-05	0.00205	CbGpPWpGaD
Disopyramide—SCN5A—L1CAM interactions—EGFR—dilated cardiomyopathy	9.31e-05	0.00203	CbGpPWpGaD
Disopyramide—SLC22A2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	9.27e-05	0.00203	CbGpPWpGaD
Disopyramide—SLC22A2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	9.27e-05	0.00203	CbGpPWpGaD
Disopyramide—CHRM2—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	9.11e-05	0.00199	CbGpPWpGaD
Disopyramide—CHRM2—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	9.11e-05	0.00199	CbGpPWpGaD
Disopyramide—SLC22A1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	8.88e-05	0.00194	CbGpPWpGaD
Disopyramide—SLC22A1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	8.64e-05	0.00189	CbGpPWpGaD
Disopyramide—SLC22A1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	8.64e-05	0.00189	CbGpPWpGaD
Disopyramide—SLC22A2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	8.62e-05	0.00188	CbGpPWpGaD
Disopyramide—CHRM1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	8.56e-05	0.00187	CbGpPWpGaD
Disopyramide—CHRM3—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	8.54e-05	0.00186	CbGpPWpGaD
Disopyramide—CHRM1—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	8.52e-05	0.00186	CbGpPWpGaD
Disopyramide—CHRM3—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	8.49e-05	0.00185	CbGpPWpGaD
Disopyramide—CHRM2—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	8.47e-05	0.00185	CbGpPWpGaD
Disopyramide—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	8.45e-05	0.00185	CbGpPWpGaD
Disopyramide—CHRM2—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	8.15e-05	0.00178	CbGpPWpGaD
Disopyramide—SLC22A1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	8.03e-05	0.00175	CbGpPWpGaD
Disopyramide—CHRM1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	7.96e-05	0.00174	CbGpPWpGaD
Disopyramide—CHRM3—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	7.94e-05	0.00173	CbGpPWpGaD
Disopyramide—CHRM2—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	7.86e-05	0.00172	CbGpPWpGaD
Disopyramide—SCN5A—Axon guidance—RAC1—dilated cardiomyopathy	7.74e-05	0.00169	CbGpPWpGaD
Disopyramide—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	7.71e-05	0.00168	CbGpPWpGaD
Disopyramide—CHRM3—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	7.69e-05	0.00168	CbGpPWpGaD
Disopyramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	7.62e-05	0.00166	CbGpPWpGaD
Disopyramide—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	7.61e-05	0.00166	CbGpPWpGaD
Disopyramide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	7.59e-05	0.00166	CbGpPWpGaD
Disopyramide—CHRM1—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	7.52e-05	0.00164	CbGpPWpGaD
Disopyramide—CHRM3—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	7.5e-05	0.00164	CbGpPWpGaD
Disopyramide—CHRM2—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	7.43e-05	0.00162	CbGpPWpGaD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	7.34e-05	0.0016	CbGpPWpGaD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	7.34e-05	0.0016	CbGpPWpGaD
Disopyramide—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	7.31e-05	0.0016	CbGpPWpGaD
Disopyramide—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	7.31e-05	0.0016	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	7.24e-05	0.00158	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	7.24e-05	0.00158	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—ITGB1—dilated cardiomyopathy	6.87e-05	0.0015	CbGpPWpGaD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	6.82e-05	0.00149	CbGpPWpGaD
Disopyramide—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	6.8e-05	0.00149	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	6.73e-05	0.00147	CbGpPWpGaD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	6.61e-05	0.00144	CbGpPWpGaD
Disopyramide—CHRM1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	6.58e-05	0.00144	CbGpPWpGaD
Disopyramide—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	6.58e-05	0.00144	CbGpPWpGaD
Disopyramide—CHRM3—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	6.56e-05	0.00143	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	6.52e-05	0.00142	CbGpPWpGaD
Disopyramide—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	6.5e-05	0.00142	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—ANKRD1—dilated cardiomyopathy	6.27e-05	0.00137	CbGpPWpGaD
Disopyramide—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	6.25e-05	0.00136	CbGpPWpGaD
Disopyramide—CHRM3—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	6.23e-05	0.00136	CbGpPWpGaD
Disopyramide—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	6.17e-05	0.00135	CbGpPWpGaD
Disopyramide—CHRM1—Circadian rythm related genes—FAS—dilated cardiomyopathy	6.04e-05	0.00132	CbGpPWpGaD
Disopyramide—SCN5A—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	6.01e-05	0.00131	CbGpPWpGaD
Disopyramide—CHRM1—G alpha (q) signalling events—AGT—dilated cardiomyopathy	5.99e-05	0.00131	CbGpPWpGaD
Disopyramide—CHRM3—G alpha (q) signalling events—AGT—dilated cardiomyopathy	5.98e-05	0.00131	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—TAZ—dilated cardiomyopathy	5.89e-05	0.00129	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—CD36—dilated cardiomyopathy	5.86e-05	0.00128	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—ANKRD1—dilated cardiomyopathy	5.84e-05	0.00128	CbGpPWpGaD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	5.64e-05	0.00123	CbGpPWpGaD
Disopyramide—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	5.62e-05	0.00123	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	5.59e-05	0.00122	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	5.59e-05	0.00122	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—AGTR2—dilated cardiomyopathy	5.57e-05	0.00122	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—CXCL2—dilated cardiomyopathy	5.57e-05	0.00122	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	5.57e-05	0.00122	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—RAC1—dilated cardiomyopathy	5.52e-05	0.00121	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	5.52e-05	0.0012	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	5.52e-05	0.0012	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—TAZ—dilated cardiomyopathy	5.49e-05	0.0012	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—ANKRD1—dilated cardiomyopathy	5.39e-05	0.00118	CbGpPWpGaD
Disopyramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	5.36e-05	0.00117	CbGpPWpGaD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	5.35e-05	0.00117	CbGpPWpGaD
Disopyramide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	5.34e-05	0.00117	CbGpPWpGaD
Disopyramide—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	5.34e-05	0.00117	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—SDHA—dilated cardiomyopathy	5.33e-05	0.00116	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	5.28e-05	0.00115	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	5.19e-05	0.00113	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—CXCR3—dilated cardiomyopathy	5.18e-05	0.00113	CbGpPWpGaD
Disopyramide—SCN5A—Axon guidance—RAF1—dilated cardiomyopathy	5.13e-05	0.00112	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	5.13e-05	0.00112	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—TAZ—dilated cardiomyopathy	5.07e-05	0.00111	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	5.03e-05	0.0011	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—ADRB1—dilated cardiomyopathy	5.01e-05	0.0011	CbGpPWpGaD
Disopyramide—CHRM1—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	4.99e-05	0.00109	CbGpPWpGaD
Disopyramide—CHRM3—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	4.97e-05	0.00109	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	4.97e-05	0.00108	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—SDHA—dilated cardiomyopathy	4.97e-05	0.00108	CbGpPWpGaD
Disopyramide—CHRM2—G alpha (i) signalling events—AGT—dilated cardiomyopathy	4.93e-05	0.00108	CbGpPWpGaD
Disopyramide—CHRM2—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	4.93e-05	0.00108	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—SDHA—dilated cardiomyopathy	4.59e-05	0.001	CbGpPWpGaD
Disopyramide—SLC22A2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	4.56e-05	0.000997	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	4.3e-05	0.000938	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—AGTR1—dilated cardiomyopathy	4.28e-05	0.000935	CbGpPWpGaD
Disopyramide—SLC22A1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	4.25e-05	0.000929	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	4.24e-05	0.000926	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	4.08e-05	0.00089	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—ADRB2—dilated cardiomyopathy	4.06e-05	0.000887	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	4.02e-05	0.000879	CbGpPWpGaD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	3.97e-05	0.000867	CbGpPWpGaD
Disopyramide—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	3.96e-05	0.000864	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	3.92e-05	0.000856	CbGpPWpGaD
Disopyramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	3.72e-05	0.000813	CbGpPWpGaD
Disopyramide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	3.71e-05	0.00081	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—RAF1—dilated cardiomyopathy	3.66e-05	0.0008	CbGpPWpGaD
Disopyramide—SCN5A—Axon guidance—EGFR—dilated cardiomyopathy	3.52e-05	0.000768	CbGpPWpGaD
Disopyramide—SLC22A2—Neuronal System—RAF1—dilated cardiomyopathy	3.5e-05	0.000764	CbGpPWpGaD
Disopyramide—CHRM1—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	3.42e-05	0.000747	CbGpPWpGaD
Disopyramide—CHRM3—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	3.41e-05	0.000745	CbGpPWpGaD
Disopyramide—CHRM2—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	3.38e-05	0.000738	CbGpPWpGaD
Disopyramide—SLC22A1—Neuronal System—RAF1—dilated cardiomyopathy	3.26e-05	0.000712	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	3.16e-05	0.00069	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	3.16e-05	0.00069	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	3.15e-05	0.000687	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	3.15e-05	0.000687	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	3.12e-05	0.000681	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	3.12e-05	0.000681	CbGpPWpGaD
Disopyramide—CHRM2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	3.1e-05	0.000677	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—AGT—dilated cardiomyopathy	3.02e-05	0.00066	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—AGT—dilated cardiomyopathy	3.01e-05	0.000658	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—AGT—dilated cardiomyopathy	2.98e-05	0.000652	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	2.94e-05	0.000641	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	2.93e-05	0.000639	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	2.9e-05	0.000633	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	2.87e-05	0.000626	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	2.87e-05	0.000626	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—CXCL2—dilated cardiomyopathy	2.86e-05	0.000624	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—AGTR2—dilated cardiomyopathy	2.86e-05	0.000624	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	2.84e-05	0.000621	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	2.83e-05	0.000619	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	2.83e-05	0.000618	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	2.83e-05	0.000618	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	2.81e-05	0.000613	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	2.67e-05	0.000582	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—CXCR3—dilated cardiomyopathy	2.66e-05	0.00058	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	2.63e-05	0.000575	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	2.58e-05	0.000564	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—ADRB1—dilated cardiomyopathy	2.57e-05	0.000562	CbGpPWpGaD
Disopyramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	2.55e-05	0.000557	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	2.55e-05	0.000557	CbGpPWpGaD
Disopyramide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	2.54e-05	0.000556	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—EGFR—dilated cardiomyopathy	2.51e-05	0.000548	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	2.43e-05	0.00053	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	2.42e-05	0.000529	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	2.4e-05	0.000523	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—TNF—dilated cardiomyopathy	2.39e-05	0.000522	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	2.3e-05	0.000503	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	2.3e-05	0.000502	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	2.27e-05	0.000497	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	2.2e-05	0.000482	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—AGTR1—dilated cardiomyopathy	2.2e-05	0.00048	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	2.18e-05	0.000475	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	2.11e-05	0.000461	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	2.09e-05	0.000457	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—ADRB2—dilated cardiomyopathy	2.08e-05	0.000455	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	2.06e-05	0.000451	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	1.98e-05	0.000433	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.91e-05	0.000417	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.9e-05	0.000415	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.88e-05	0.000411	CbGpPWpGaD
Disopyramide—SLC22A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.88e-05	0.000411	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	1.79e-05	0.000392	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.79e-05	0.000391	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.78e-05	0.000389	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.77e-05	0.000386	CbGpPWpGaD
Disopyramide—SLC22A1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.75e-05	0.000383	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.71e-05	0.000373	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.7e-05	0.000372	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.69e-05	0.00037	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.69e-05	0.00037	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.69e-05	0.000369	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.69e-05	0.000369	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.69e-05	0.000368	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.67e-05	0.000365	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.67e-05	0.000365	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.62e-05	0.000355	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.62e-05	0.000354	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.6e-05	0.00035	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.57e-05	0.000344	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.57e-05	0.000343	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.55e-05	0.00034	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—AGT—dilated cardiomyopathy	1.55e-05	0.000339	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—AGT—dilated cardiomyopathy	1.55e-05	0.000338	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—AGT—dilated cardiomyopathy	1.53e-05	0.000335	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.52e-05	0.000333	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.52e-05	0.000332	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.51e-05	0.000329	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—GPX1—dilated cardiomyopathy	1.45e-05	0.000316	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—CD36—dilated cardiomyopathy	1.41e-05	0.000308	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—GPX1—dilated cardiomyopathy	1.35e-05	0.000295	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—CD36—dilated cardiomyopathy	1.31e-05	0.000287	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.3e-05	0.000284	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.3e-05	0.000284	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.29e-05	0.000281	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—AGT—dilated cardiomyopathy	1.27e-05	0.000277	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—GPX1—dilated cardiomyopathy	1.25e-05	0.000272	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.24e-05	0.00027	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.23e-05	0.000269	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.22e-05	0.000266	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—CD36—dilated cardiomyopathy	1.21e-05	0.000265	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—AGT—dilated cardiomyopathy	1.18e-05	0.000258	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—AGT—dilated cardiomyopathy	1.09e-05	0.000239	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.08e-05	0.000235	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.07e-05	0.000234	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.06e-05	0.000232	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.06e-05	0.000232	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.06e-05	0.000231	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.05e-05	0.000229	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—RAC1—dilated cardiomyopathy	9.59e-06	0.00021	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—RAC1—dilated cardiomyopathy	9.56e-06	0.000209	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—RAC1—dilated cardiomyopathy	9.47e-06	0.000207	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—AGT—dilated cardiomyopathy	9.16e-06	0.0002	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—AGT—dilated cardiomyopathy	9.14e-06	0.0002	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—AGT—dilated cardiomyopathy	9.05e-06	0.000198	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—EGFR—dilated cardiomyopathy	7.38e-06	0.000161	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—EGFR—dilated cardiomyopathy	7.36e-06	0.000161	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—EGFR—dilated cardiomyopathy	7.29e-06	0.000159	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—RAF1—dilated cardiomyopathy	6.36e-06	0.000139	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—RAF1—dilated cardiomyopathy	6.34e-06	0.000138	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—RAF1—dilated cardiomyopathy	6.28e-06	0.000137	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	4.87e-06	0.000106	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	4.74e-06	0.000104	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—EGFR—dilated cardiomyopathy	4.36e-06	9.53e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—EGFR—dilated cardiomyopathy	4.35e-06	9.5e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—EGFR—dilated cardiomyopathy	4.31e-06	9.4e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	4.27e-06	9.33e-05	CbGpPWpGaD
